{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:53:44Z","timestamp":1772240024209,"version":"3.50.1"},"reference-count":45,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2008]]},"DOI":"10.3164\/jcbn.2008028","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T05:51:48Z","timestamp":1209534708000},"page":"191-196","source":"Crossref","is-referenced-by-count":19,"title":["Gastric Epithelial Cell Modality and Proton Pump Inhibitor"],"prefix":"10.3164","volume":"42","author":[{"given":"Tatsuhiro","family":"Masaoka","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine"},{"name":"Department of Gastroenterology, Eiju general Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"[1] Shull, G.E. and Lingrel, J.B.: Molecular cloning of the rat stomach (H+ + K+)-ATPase. J. Biol. Chem., 261, 16788–16791, 1986.","DOI":"10.1016\/S0021-9258(19)75957-2"},{"key":"2","doi-asserted-by":"crossref","unstructured":"[2] Yeo, M., Kim, K.D., Chung, S.I., Moon, S.B., Song, S.K., and Hahm, B.K.: The Novel Acid Pump Antagonists for Anti-secretory Actions with Their Peculiar Applications Beyond Acid Suppression. J. Clin. Biochem. Nutr., 38, 1–8, 2006.","DOI":"10.3164\/jcbn.38.1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"[3] Besancon, M., Simon, A., Sachs, G., and Shin, J.M.: Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J. Biol. Chem., 272, 22438–22446, 1997.","DOI":"10.1074\/jbc.272.36.22438"},{"key":"4","doi-asserted-by":"crossref","unstructured":"[4] Nakamura, M., Matsui, H., Serizawa, H., and Tsuchimoto, K.: Lansoprazole Novel Effector Sites Revealed by Autoradiography: Relation to Helicobacter pylori, Colon, Esophagus and Others. J. Clin. Biochem. Nutr., 41, 154–159, 2007.","DOI":"10.3164\/jcbn.2007021"},{"key":"5","unstructured":"[5] Mears, J.M. and Kaplan, B.: Proton pump inhibitors: new drugs and indications. Am. Fam. Physician., 53, 285–292, 1996."},{"key":"6","doi-asserted-by":"crossref","unstructured":"[6] Karam, S.M. and Leblond, C.P.: Dynamics of epithelial cells in the corpus of the mouse stomach. II. Outward migration of pit cells. Anat. Rec., 236, 280–296, 1993.","DOI":"10.1002\/ar.1092360203"},{"key":"7","doi-asserted-by":"crossref","unstructured":"[7] Karam, S.M. and Leblond, C.P.: Dynamics of epithelial cells in the corpus of the mouse stomach. III. Inward migration of neck cells followed by progressive transformation into zymogenic cells. Anat. Rec., 236, 297–313, 1993.","DOI":"10.1002\/ar.1092360204"},{"key":"8","doi-asserted-by":"crossref","unstructured":"[8] Karam, S.M.: Dynamics of epithelial cells in the corpus of the mouse stomach. IV. Bidirectional migration of parietal cells ending in their gradual degeneration and loss. Anat. Rec., 236, 314–332, 1993.","DOI":"10.1002\/ar.1092360205"},{"key":"9","unstructured":"[9] Karam, S.M. and Leblond, C.P.: Dynamics of epithelial cells in the corpus of the mouse stomach. V. Behavior of entero-endocrine and caveolated cells: general conclusions on cell kinetics in the oxyntic epithelium. Anat. Rec., 236, 333–340, 1993."},{"key":"10","doi-asserted-by":"crossref","unstructured":"[10] Forte, J.G., Forte, T.M., Black, J.A., Okamoto, C., and Wolosin, J.M.: Correlation of parietal cell structure and function. J. Clin. Gastroenterol., 5 Suppl 1, 17–27, 1983.","DOI":"10.1097\/00004836-198312001-00003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"[11] Karasawa, H., Tani, N., and Miwa, T.: The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol. Jpn., 23, 1–8, 1988.","DOI":"10.1007\/BF02918848"},{"key":"12","doi-asserted-by":"crossref","unstructured":"[12] Spicer, Z., Miller, M.L., Andringa, A., Riddle, T.M., Duffy, J.J., Doetschman, T., and Shull, G.E.: Stomachs of mice lacking the gastric H,K-ATPase alpha-subunit have achlorhydria, abnormal parietal cells, and ciliated metaplasia. J. Biol. Chem., 275, 21555–21565, 2000.","DOI":"10.1074\/jbc.M001558200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"[13] Grahammer, F., Herling, A.W., Lang, H.J., Schmitt-Graff, A., Wittekindt, O.H., Nitschke, R., Bleich, M., Barhanin, J., and Warth, R.: The cardiac K+ channel KCNQ1 is essential for gastric acid secretion. Gastroenterology, 120, 1363–1371, 2001.","DOI":"10.1053\/gast.2001.24053"},{"key":"14","doi-asserted-by":"crossref","unstructured":"[14] Heitzmann, D., Grahammer, F., von Hahn, T., Schmitt-Graff, A., Romeo, E., Nitschke, R., Gerlach, U., Lang, H.J., Verrey, F., Barhanin, J., and Warth, R.: Heteromeric KCNE2\/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells. J. Physiol., 561, 547–557, 2004.","DOI":"10.1113\/jphysiol.2004.075168"},{"key":"15","doi-asserted-by":"crossref","unstructured":"[15] Elso, C.M., Lu, X., Culiat, C.T., Rutledge, J.C., Cacheiro, N.L., Generoso, W.M., and Stubbs, L.J.: Heightened susceptibility to chronic gastritis, hyperplasia and metaplasia in Kcnq1 mutant mice. Hum. Mol. Genet., 13, 2813–2821, 2004.","DOI":"10.1093\/hmg\/ddh307"},{"key":"16","doi-asserted-by":"crossref","unstructured":"[16] Roepke, T.K., Anantharam, A., Kirchhoff, P., Busque, S.M., Young, J.B., Geibel, J.P., Lerner, D.J., and Abbott, G.W.: The KCNE2 potassium channel ancillary subunit is essential for gastric acid secretion. J. Biol. Chem., 281, 23740–23747, 2006.","DOI":"10.1074\/jbc.M604155200"},{"key":"17","doi-asserted-by":"crossref","unstructured":"[17] Franic, T.V., Judd, L.M., Robinson, D., Barrett, S.P., Scarff, K.L., Gleeson, P.A., Samuelson, L.C., and Van Driel, I.R.: Regulation of gastric epithelial cell development revealed in H(+)\/K(+)-ATPase beta-subunit- and gastrin-deficient mice. Am. J. Physiol. Gastrointest. Liver Physiol., 281, G1502–1511, 2001.","DOI":"10.1152\/ajpgi.2001.281.6.G1502"},{"key":"18","doi-asserted-by":"crossref","unstructured":"[18] Helander, H.F., Simonsson, M., Sundler, F., Rutgersson, K., Helander, K.G., and Eriksson, S.: Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists. Virchows Arch A Pathol. Anat. Histopathol., 417, 305–309, 1990.","DOI":"10.1007\/BF01605781"},{"key":"19","doi-asserted-by":"crossref","unstructured":"[19] Driman, D.K., Wright, C., Tougas, G., and Riddell, R.H.: Omeprazole produces parietal cell hypertrophy and hyperplasia in humans. Dig. Dis. Sci., 41, 2039–2047, 1996.","DOI":"10.1007\/BF02093608"},{"key":"20","doi-asserted-by":"crossref","unstructured":"[20] van den Brink, G.R., Hardwick, J.C., Tytgat, G.N., Brink, M.A., Ten Kate, F.J., Van Deventer, S.J., and Peppelenbosch, M.P.: Sonic hedgehog regulates gastric gland morphogenesis in man and mouse. Gastroenterology, 121, 317–328, 2001.","DOI":"10.1053\/gast.2001.26261"},{"key":"21","doi-asserted-by":"crossref","unstructured":"[21] Suzuki, H., Minegishi, Y., Nomoto, Y., Ota, T., Masaoka, T., van den Brink, G.R., and Hibi, T.: Down-regulation of a morphogen (sonic hedgehog) gradient in the gastric epithelium of Helicobacter pylori-infected Mongolian gerbils. J. Pathol., 206, 186–197, 2005.","DOI":"10.1002\/path.1763"},{"key":"22","unstructured":"[22] Nishizawa, T., Suzuki, H., Masaoka, T., Minegishi, Y., Iwasahi, E., and Hibi, T.: Helicobacter pylori eradication restored sonic hedgehog expression in the stomach. Hepatogastroenterology, 54, 697–700, 2007."},{"key":"23","doi-asserted-by":"crossref","unstructured":"[23] Minegishi, Y., Suzuki, H., Arakawa, M., Fukushima, Y., Masaoka, T., Ishikawa, T., Wright, N.A., and Hibi, T.: Reduced Shh expression in TFF2-overexpressing lesions of the gastric fundus under hypochlorhydric conditions. J. Pathol., 213, 161–169, 2007.","DOI":"10.1002\/path.2221"},{"key":"24","doi-asserted-by":"crossref","unstructured":"[24] Kakei, N., Ichinose, M., Tatematsu, M., Shimizu, M., Oka, M., Yahagi, N., Matsushima, M., Kurokawa, K., Yonezawa, S., Furihata, C., Shiokawa, K., Kageyama, T., Miki, K., and Fukamachi, H.: Effects of long-term omeprazole treatment on adult rat gastric mucosa—enhancement of the epithelial cell proliferation and suppression of its differentiation. Biochem. Biophys. Res. Commun., 214, 861–868, 1995.","DOI":"10.1006\/bbrc.1995.2366"},{"key":"25","doi-asserted-by":"crossref","unstructured":"[25] Sachs, G., Zeng, N., and Prinz, C.: Physiology of isolated gastric endocrine cells. Annu. Rev. Physiol., 59, 243–256, 1997.","DOI":"10.1146\/annurev.physiol.59.1.243"},{"key":"26","doi-asserted-by":"crossref","unstructured":"[26] Simonsson, M., Eriksson, S., Hakanson, R., Lind, T., Lonroth, H., Lundell, L., O’Connor, D.T., and Sundler, F.: Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand. J. Gastroenterol., 23, 1089–1099, 1988.","DOI":"10.3109\/00365528809090174"},{"key":"27","doi-asserted-by":"crossref","unstructured":"[27] Bottcher, G., Hakanson, R., Nilsson, G., Seensalu, R., and Sundler, F.: Effects of long-term hypergastrinaemia on the ultrastructure of enterochromaffin-like cells in the stomach of the rat, hamster and guinea pig. Cell Tissue Res., 256, 247–257, 1989.","DOI":"10.1007\/BF00218882"},{"key":"28","doi-asserted-by":"crossref","unstructured":"[28] Lamberts, R., Creutzfeldt, W., Struber, H.G., Brunner, G., and Solcia, E.: Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology, 104, 1356–1370, 1993.","DOI":"10.1016\/0016-5085(93)90344-C"},{"key":"29","doi-asserted-by":"crossref","unstructured":"[29] Eissele, R., Brunner, G., Simon, B., Solcia, E., and Arnold, R.: Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology, 112, 707–717, 1997.","DOI":"10.1053\/gast.1997.v112.pm9041231"},{"key":"30","doi-asserted-by":"crossref","unstructured":"[30] Suzuki, H., Masaoka, T., Minegishi, Y., Motosugi, Y., Miura, S., and Ishii, H.: Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44\/p42 mitogen-activated protein kinase. Wound Repair Regen., 12, 93–99, 2004.","DOI":"10.1111\/j.1067-1927.2004.012116.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"[31] Havu, N.: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion, 35 Suppl 1, 42–55, 1986.","DOI":"10.1159\/000199381"},{"key":"32","doi-asserted-by":"crossref","unstructured":"[32] Maton, P.N., Lack, E.E., Collen, M.J., Cornelius, M.J., David, E., Gardner, J.D., and Jensen, R.T.: The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells. Gastroenterology, 99, 943–950, 1990.","DOI":"10.1016\/0016-5085(90)90611-4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"[33] Jensen, R.T., Metz, D.C., Koviack, P.D., and Feigenbaum, K.M.: Prospective study of the long-term efficacy and safety of lansoprazole in patients with the Zollinger-Ellison syndrome. Aliment Pharmacol. Ther., 7 Suppl 1, 41–50, discussion 61–66, 1993.","DOI":"10.1111\/j.1365-2036.1993.tb00588.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"[34] Date, Y., Kojima, M., Hosoda, H., Sawaguchi, A., Mondal, M.S., Suganuma, T., Matsukura, S., Kangawa, K., and Nakazato, M.: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology, 141, 4255–4261, 2000.","DOI":"10.1210\/endo.141.11.7757"},{"key":"35","doi-asserted-by":"crossref","unstructured":"[35] Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H., and Kangawa, K.: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 402, 656–660, 1999.","DOI":"10.1038\/45230"},{"key":"36","doi-asserted-by":"crossref","unstructured":"[36] Mori, M., Suzuki, H., Masaoka, T., Imaeda, H., Nomoto, Y., Hosoda, H., Nishizawa, T., Kangawa, K., and Hibi, T.: Intravenous ghrelin administration enhances gastric acid secretion—evaluation using wireless pH capsule. Aliment Pharmacol. Ther., 24 Suppl 4, 96–103, 2006.","DOI":"10.1111\/j.1365-2036.2006.00031.x"},{"key":"37","doi-asserted-by":"crossref","unstructured":"[37] Cui, G.L., Syversen, U., Zhao, C.M., Chen, D., and Waldum, H.L.: Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. Scand. J. Gastroenterol., 36, 1011–1015, 2001.","DOI":"10.1080\/003655201750422585"},{"key":"38","doi-asserted-by":"crossref","unstructured":"[38] Suzuki, H., Masaoka, T., Hosoda, H., Ota, T., Minegishi, Y., Nomura, S., Kangawa, K., and Ishii, H.: Helicobacter pylori<\/i> infection modifies gastric and plasma ghrelin dynamics in Mongolian gerbils. Gut, 187–194, 2004.","DOI":"10.1136\/gut.2003.021568"},{"key":"39","unstructured":"[39] Suzuki, H., Masaoka, T., Hosoda, H., Nomura, S., Ohara, T., Kangawa, K., Ishii, H., and Hibi, T.: Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I\/II ratio – a possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterol., 1249–1254, 2004."},{"key":"40","doi-asserted-by":"crossref","unstructured":"[40] Kuipers, E.J., Lundell, L., Klinkenberg-Knol, E.C., Havu, N., Festen, H.P., Liedman, B., Lamers, C.B., Jansen, J.B., Dalenback, J., Snel, P., Nelis, G.F., and Meuwissen, S.G.: Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N. Engl. J. Med., 334, 1018–1022, 1996.","DOI":"10.1056\/NEJM199604183341603"},{"key":"41","doi-asserted-by":"crossref","unstructured":"[41] Lundell, L., Miettinen, P., Myrvold, H.E., Pedersen, S.A., Thor, K., Andersson, A., Hattlebakk, J., Havu, N., Janatuinen, E., Levander, K., Liedman, B., and Nystrom, P.: Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. Gastroenterology, 117, 319–326, 1999.","DOI":"10.1053\/gast.1999.0029900319"},{"key":"42","doi-asserted-by":"crossref","unstructured":"[42] Kuipers, E.J., Nelis, G.F., Klinkenberg-Knol, E.C., Snel, P., Goldfain, D., Kolkman, J.J., Festen, H.P., Dent, J., Zeitoun, P., Havu, N., Lamm, M., and Walan, A.: Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut, 53, 12–20, 2004.","DOI":"10.1136\/gut.53.1.12"},{"key":"43","doi-asserted-by":"crossref","unstructured":"[43] Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Mashiba, H., Sasaki, N., and Taniyama, K.: Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during long-term acid-suppressive treatment in Japan. Aliment Pharmacol. Ther., 14, 1345–1352, 2000.","DOI":"10.1046\/j.1365-2036.2000.00834.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"[44] Jalving, M., Koornstra, J.J., Wesseling, J., Boezen, H.M., S, D.E.J., and Kleibeuker, J.H.: Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol. Ther., 24, 1341–1348, 2006.","DOI":"10.1111\/j.1365-2036.2006.03127.x"},{"key":"45","doi-asserted-by":"crossref","unstructured":"[45] Vieth, M. and Stolte, M.: Fundic gland polyps are not induced by proton pump inhibitor therapy. Am. J. Clin. Pathol., 116, 716–720, 2001.","DOI":"10.1309\/XFWR-LXA7-7TK1-N3Q8"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/42\/3\/42_2008028\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T05:37:31Z","timestamp":1631165851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/42\/3\/42_2008028\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.2008028","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}